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Phosphatidylinositol-4-phosphate (PI4P), a phosphoinositide with key roles in the Golgi complex, is made by Golgi-
associated phosphatidylinositol-4 kinases and consumed by the 4-phosphatase Sac1 that, instead, is an ER membrane 
protein. Here, we show that the contact sites between the ER and the TGN (ERTGoCS) provide a spatial setting suitable for 
Sac1 to dephosphorylate PI4P at the TGN. The ERTGoCS, though necessary, are not sufficient for the phosphatase activity of 
Sac1 on TGN PI4P, since this needs the phosphatidyl-four-phosphate-adaptor-protein-1 (FAPP1). FAPP1 localizes at ERTGoCS, 
interacts with Sac1, and promotes its in-trans phosphatase activity in vitro. We envision that FAPP1, acting as a PI4P detector 
and adaptor, positions Sac1 close to TGN domains with elevated PI4P concentrations allowing PI4P consumption. Indeed, 
FAPP1 depletion induces an increase in TGN PI4P that leads to increased secretion of selected cargoes (e.g., ApoB100),  
indicating that FAPP1, by controlling PI4P levels, acts as a gatekeeper of Golgi exit.
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Introduction
Phosphatidylinositol-4-phosphate (PI4P) is a phosphoinositide 
that has a pivotal role at the Golgi, in particular at the TGN, where 
it is enriched (Balla, 2013; De Matteis et al., 2013). PI4P mediates 
the association of adaptor proteins involved in cargo sorting, re-
cruits components involved in carrier budding and fission, and 
drives sphingolipid synthesis and cholesterol transfer from the 
ER to the TGN (Hanada et al., 2003; Godi et al., 2004; D’Angelo 
et al., 2007, 2008; Valente et al., 2012; Mesmin et al., 2013). The 
steady-state levels of PI4P at the TGN are maintained by two 
phosphatidylinositol-4 kinases (PI4Ks; PI4KIIIβ and PI4KIIα) 
and one 4-phosphatase (Sac1). While the PI4Ks are cytosolic pro-
teins associated with the Golgi complex (Balla, 2013), Sac1 is an 
integral membrane protein that resides in the ER and cycles be-
tween the ER and early Golgi compartments (without reaching 
the TGN) in normally growing cells (Cheong et al., 2010) through 
COP II- and COPI-mediated anterograde and retrograde traffick-
ing, respectively (Rohde et al., 2003; Bajaj Pahuja et al., 2015). 
One way for Sac1 to gain access to PI4P in the TGN could be to 
exploit the ER–TGN contact sites (ERTGoCS; Hsu and Mao, 2015). 
However, the gaps in our knowledge about ERTGoCS, mainly due 
to methodological limits, have hampered direct studies to address 
this question. We therefore developed a Förster resonance energy 
transfer–based approach (Grecco and Bastiaens, 2013), which is 
endowed with the necessary nanoscale resolution power for the 
study of ERTGoCS that enabled us to identify some of the com-
ponents required to establish/maintain the contacts (see Venditti 
et al. in this issue). These include the ER resident proteins VAPA 
and VAPB; the lipid transfer protein ORP10 which transfers PS; 
and OSBP1 and ORP9, which transfer cholesterol and play a re-
dundant role in the maintenance of the ERTGoCS.
Here, we exploited the knowledge gained on the molecular 
requirements for ERTGoCS to address the question of whether 
and how they control the levels of PI4P at the TGN.
Results and discussion
Destabilizing the ERTGoCS increases PI4P levels at the TGN
To assess the role of ERTGoCS in controlling PI4P at the TGN, we 
evaluated what happens to TGN PI4P levels after depletion of 
the very same set of proteins we had tested for their effects on 
ERTGoCS, i.e., the VAP proteins (VAPA and VAPB) and the lipid 
transfer proteins that are associated with the Golgi complex 
(OSBP1, ORP9, ORP10, ORP11, CERT, FAPP1, and FAPP2).
We have shown (Venditti et al., 2019) that either depleting 
VAP proteins or ORP10, or the combined depletion of ORP9 and 
OSBP1, are the only conditions that destabilize ERTGoCS. Ana-
lyzing the levels of PI4P at the TGN by immunostaining, we ob-
served that, in general, there is a very good correlation between 
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conditions that induce the destabilization of ERTGoCS (Fig. 4 in 
Venditti et al., 2019) and those that cause an increase in PI4P lev-
els at the TGN (Fig. 1, A–C). Indeed, only VAP depletion, ORP10 
depletion, and the combined depletion of OSBP1 and ORP9 led 
to increased levels of PI4P at the TGN, indicating that the close 
proximity of ER and TGN membranes is a prerequisite for Sac1 
to dephosphorylate Golgi PI4P (Fig. 1, A–C).
FAPP1 depletion causes an increase in Golgi PI4P without 
affecting the stability of the ERTGoCS
One notable exception to the general correlation between ERT-
GoCS destabilization and the increase in Golgi PI4P was FAPP1, 
whose depletion had no effect on the number or integrity of ERT-
GoCS (Fig. 4 in Venditti et al., 2019) but markedly increased Golgi 
PI4P levels (Fig. 1, A, B, and D). The increase in Golgi PI4P levels 
was evaluated by four independent approaches: three imaging 
approaches and a biochemical one. The imaging approaches 
were based on the use of an anti-PI4P antibody (Hammond et 
al., 2009; Fig. 1, A–D), on the expression of two different geneti-
cally encoded PI4P probes (P4C and P4M; Hammond et al., 2014; 
Luo et al., 2015; Fig. 1, E and F; and Fig. S1, A and B), and on the 
staining of permeabilized cells with a recombinant PI4P probe 
(the PH domain of FAPP1; Godi et al., 2004; Fig. S1 C). The bio-
chemical approach was based on a mass assay in which Golgi 
fractions were incubated with recombinant PI4P 5-kinase type-1 
γ (PIP5K1C) and [γ-32P]-ATP. The amount of 32P-PI4,5P2 gener-
ated under these conditions and assessed by TLC is a measure of 
the PI4P 5-kinase substrate (i.e., PI4P) present in the membranes. 
A higher amount of PI4,5P2 was produced by PIP5K1C incubated 
with Golgi fractions isolated from FAPP1-depleted cells as com-
pared with control cells (Fig. 1, G and H), confirming that FAPP1 
depletion increases Golgi PI4P.
Importantly, the effect of FAPP1 depletion on PI4P was res-
cued by the expression of siRNA-resistant forms of FAPP1 
(Fig. 1 D) and, more importantly, fibroblasts from FAPP1-KO mice 
exhibited an increase in PI4P levels in the Golgi (in comparison 
to control fibroblasts) that was reverted by the expression of 
human FAPP1 (Figs. 1 D and S1 D). These results indicated that 
the balance of PI4P at the Golgi requires ERTGoCS integrity and 
functional FAPP1.
FAPP1 interacts with VAPs and Sac1
FAPP1, encoded by the PLE KHA3 gene, was among the first mam-
malian PI4P-binding proteins to be identified (Dowler et al., 
2000), but its role has remained elusive so far (D’Angelo et al., 
2007; De Matteis et al., 2007). Our observation that FAPP1 con-
trols PI4P levels at the Golgi, but not the integrity of ERTGoCS, 
prompted us to investigate the molecular mechanisms underly-
ing this control. We combined proximity-biotinylation (Fig. 2 A), 
coimmunoprecipitation (Fig. S2, A and B), and in vitro binding 
assays with recombinant proteins (Fig. 2, B and C) to look for 
and validate FAPP1 interactors and found that FAPP1 interacts 
directly and forms a tripartite complex with VAP proteins and 
Sac1 (Fig. 2, A–C). We dissected the domains of FAPP1 involved in 
these interactions and found that it binds the N-terminal regu-
latory domain of Sac1 via its N-terminal domain and VAPA via its 
C-terminal region (Fig. 2, B and C).
The interaction of FAPP1, a TGN-associated protein, with two 
ER proteins (VAP and Sac1) prompted us to investigate whether 
FAPP1 localizes at ERTGoCS and whether the interaction of FAPP1 
with Sac1 had any impact on the phosphatase activity of Sac1. 
Using super-resolution microscopy and immuno-EM, we were 
able to visualize FAPP1 at sites of apposition of the TGN with the 
ER (Fig. 2, D and E).
FAPP1 promotes the in-trans phosphatase activity of Sac1
We then assessed whether FAPP1 could affect the 4-phospha-
tase activity of Sac1. This was tested in vitro using recombinant 
human proteins (Sac1 and FAPP1) and reconstituting different 
configurations of enzyme–substrate interaction (cis, trans, 
or soluble forms of the substrate). We found that the in-trans 
phosphatase activity of Sac1 is rather low, in agreement with 
previous reports obtained with yeast Sac1 (Mesmin et al., 2013), 
but is markedly stimulated by FAPP1 in a dose-dependent man-
ner (Fig. 2, F and H). Intriguingly, FAPP1 behaved as a power-
ful activator of the dephosphorylation of PI4P by Sac1 in trans, 
while it had a much smaller effect on the dephosphorylation 
of PI4P in cis and no effect on the dephosphorylation of a sol-
uble form of PI4P by Sac1 (Fig. 2, F and G). We asked whether 
FAPP1 could “present” PI4P to Sac1, in which case it should be 
able to extract PI4P from membranes, but found that this was 
not the case (Fig. 2  I). We also checked whether the Sac1 de-
phosphorylation of PI4P that is stimulated by FAPP1 might be 
due to a possible liposome aggregation activity of FAPP1. This 
was not the case since FAPP1 exhibited no liposome aggrega-
tion activity at concentrations that were effective in stimulat-
ing Sac1 phosphatase activity. Slight liposome aggregation was 
observed only with the highest concentrations of FAPP1, which, 
however, stimulated Sac1 activity 10-fold more than an artifi-
cial tether, inducing comparable levels of liposome aggregation 
(Fig. S2, C and D).
Increasing the stability of ERTGoCs decreases Golgi PI4P in a 
FAPP1-dependent manner
The above results indicate that FAPP1 activates the in-trans ac-
tivity of Sac1 in vitro. We then assessed whether this could also 
occur in cells. To this end we developed an optogenetics approach 
to stabilize ERTGoCS in a reversible manner and to simultane-
ously follow the levels of PI4P. The light-oxygen-voltage (LOV)–
sensitive domain of phototropin was fused to SsrA and the ER 
reporter domain (Cb5), while the reciprocal peptide Sspb was 
fused to the TGN reporter protein (TGN46; Lungu et al., 2012; 
Guntas et al., 2015; Fig. 3, A and B). In the absence of illumina-
tion, Cb5 had a diffuse ER distribution but concentrated around 
the Golgi area after blue light illumination. This concentration 
was lost when the blue light was removed (Fig. 3 C and Video 1). 
The simultaneous detection of PI4P levels by the PI4P probe P4M 
(Hammond et al., 2014) in living cells (Fig. 3, C and D; and Video 1) 
or by the anti-PI4P antibody (Hammond et al., 2009) in fixed cells 
(Fig. 3, E and F) showed an anti-phasic trend, with the levels of 
TGN PI4P decreasing in coincidence with the increased stabil-
ity of the ERTGoCS (Fig. 3, D–F; and Video 1). Importantly, this 
decrease was dependent on FAPP1, as it was blunted in FAPP1- 
depleted cells (Fig. 3 D).
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Figure 1. The depletion of VAPs, ORP10, and ORP9 in combination with OSBP1, or of FAPP1 increases Golgi PI4P. (A) Immunodetection of PI4P with 
a monoclonal anti-PI4P antibody in control (CTRL), FAPP1-KD, ORP10-KD, and VAP-KD HeLa cells fixed and costained with anti–Golgin-97 antibody. Bar, 10 
µm. (B and C) Quantification of Golgi PI4P levels (the ratio of PI4P and Golgin-97 fluorescence intensity at the Golgi complex; see Materials and methods) in 
cells transfected with the indicated single (B) or double (C) siRNAs. Means ± SD, three independent experiments, n > 200 cells per experiment; Student’s t 
test. Bar, 10 µm. (D) PI4P levels in control and FAPP1-KD HeLa cells and in WT and FAPP1-KO MEFs with (+FAPP1) or without GFP-FAPP1 overexpression. Top 
panel: Representative images of the MEFs. The arrowhead in a lower panel indicates a cell overexpressing GFP-FAPP1. Graph: Quantification of Golgi PI4P levels 
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In a parallel approach, we stabilized ERTGoCS, using rapamy-
cin to induce the heterodimerization of the ER and TGN reporter 
proteins containing the FKBP and FRB domains, respectively 
(Fig. 3, G and H). The stabilization of ERTGoCS induced by rapa-
mycin resulted in a decrease in PI4P levels, which was faster and 
more pronounced than that induced by the optogenetics-based 
stabilization (Fig. 3 E), possibly due to the different geometries, 
efficiency, and stability of the induced dimers.
The levels of TGN PI4P were reduced by 60% and by 80% 
upon 2–4-min and 15-min treatments with rapamycin in con-
trol cells, respectively (Fig. 3, I and J). The decrease in PI4P levels 
was less pronounced in FAPP1-depleted cells, consistent with 
the involvement of FAPP1 in controlling the phosphatase activ-
ity of Sac1 (Fig. 3, I and J). The observed decrease of Golgi PI4P 
induced by ERTGoCS stabilization in FAPP1-depleted cells may 
be due to a residual fraction of FAPP1 or to a FAPP1-independent 
in-trans activity of Sac1 under conditions of forced stabilization 
of the ERTGoCS, or, to an in-cis activity of Sac1 sustained by the 
transfer of PI4P from the TGN to the ER via the lipid transfer 
proteins OSBP1 and/or ORP9 (Ngo and Ridgway, 2009; Mesmin et 
al., 2013). We thus applied the above ERTGoCS-stabilizing treat-
ments to conditions, such as VAP depletion (by siRNA or tran-
scription activator–like effector nuclease [TAL EN]), that prevent 
TGN-to-ER transfer of PI4P by OSBP1 or ORP9 (as VAPs are the 
necessary ER anchors for these lipid transfer proteins; Murphy 
and Levine, 2016).
Under these conditions, the TGN PI4P has to be obligatorily 
consumed in trans by Sac1. We first checked the ability of the 
treatments to stabilize the ERTGoCS. While short treatments (2–4 
min) with rapamycin, which induced stabilization of ERTGoCS in 
control cells, were ineffective in VAP-depleted cells, longer rapa-
mycin treatment (15 min) could induce a significant stabilization 
of ERTGoCS even in VAP-depleted cells (Fig. 3, I–K). Of note, the 
15-min treatment (but not the 2–4-min treatments) could also 
reduce the elevated PI4P levels in VAP-depleted cells (Fig. 3, I–K), 
but only in the presence of FAPP1, since the stabilization of the 
ERTGoCS in cells depleted both for VAPs and FAPP1 had no effect 
on the elevated PI4P levels in these cells (Fig. 3, I and J), in line 
with the requirement of FAPP1 for the in-trans 4-phosphatase 
activity of Sac1, and also with the observation that FAPP1, at least 
in vitro, can promote the in-trans activity of Sac1 in the absence 
of VAPs (Fig. 2, F and H).
FAPP1 negatively controls the secretion of ApoB100 in 
hepatocytes by titrating PI4P levels at the TGN
Having uncovered a role for FAPP1 as a controller of PI4P at the 
TGN, we wondered about the functional relevance of such a role. 
In addressing this question, we were guided by the reported 
observation that the depletion of ORP10, which leads to an in-
crease in Golgi PI4P analogous to that induced by FAPP1 depletion 
(Fig. 1, A and B), stimulates the secretion of ApoB100, but not of 
albumin, in hepatocytes (Nissilä et al., 2012). Interestingly, the 
role of ORP10 as a negative controller of ApoB100 secretion has 
been proposed as a possible explanation for the association of 
ORP10 single-nucleotide polymorphisms with dyslipidemia and 
peripheral arterial disease (Perttilä et al., 2009; Koriyama et al., 
2010; Nissilä et al., 2012). Thus, we assessed the role of FAPP1 
in ApoB100 secretion. We found that FAPP1 and ORP10 act as 
negative regulators of TGN PI4P and that FAPP1, like ORP10, 
negatively regulates ApoB100 secretion in HepG2 cells (Fig. 4, 
A–E). Indeed, the depletion of FAPP1 induced an increase in the 
secretion of ApoB100, as evaluated by Western blot (Fig. 4, A and 
B), ELI SA (Fig. 4 C), and pulse-chase analysis of newly synthe-
sized ApoB100 (Fig. 4 D), while it did not affect the secretion of 
other newly synthesized cargoes, such as albumin and α1-anti- 
trypsin (Fig. 4 D).
To identify the trafficking step of ApoB100 that is sensitive 
to FAPP1 regulation, we devised a synchronization protocol 
whereby newly synthesized ApoB100 was first accumulated in 
the TGN (by lowering the temperature to 20°C) and then allowed 
to exit the TGN by increasing the temperature to 37°C. We found 
that FAPP1 depletion accelerates the exit of ApoB100 from the 
TGN (Fig. 4, G and H) and increased the number of post-Golgi 
carriers containing ApoB100 (Fig. 4 I). Importantly, the acceler-
ated Golgi-emptying of ApoB100 was blunted by the simultane-
ous depletion of PI4KIIIβ, indicating that it was due to increased 
PI4P levels (Fig. 4 H). The above data indicate that FAPP1 titrates 
PI4P to levels that limit the rate of transport of selected cargoes, 
such as ApoB100, which use dedicated carriers to leave the TGN 
(Hossain et al., 2014).
Here, we have identified that FAPP1, a protein with an enig-
matic function so far (D’Angelo et al., 2007; De Matteis et al., 
2007), is a regulator of Golgi PI4P levels, which can activate 
the in-trans 4-phosphatase activity of Sac1. We envisage that 
FAPP1, faithful to its original name of phosphatidyl-four-phos-
phate-adaptor-protein-1 (Dowler et al., 2000), acts as an adaptor 
between PI4P-enriched TGN domains and Sac1 in the ER mem-
branes, boosting, but at the same time restricting in space, its 
phosphatase activity across the ERTGoCS. In yeast, targeting the 
activity of Sac1 toward a specific pool of PI4P (in the early Golgi 
compartments) has been proposed for Vps74 (Wood et al., 2012).
Sac1 can also act in cis on PI4P that is transferred from the TGN 
to the ER by OSBP1 in counter-exchange with cholesterol (Mesmin 
et al., 2013). We believe that the two modes of Sac1 activity coexist 
in control and FAPP1-KD HeLa cells and in WT and FAPP1-KO MEFs, with (+FAPP1) or without GFP-FAPP1 overexpression. Means ± SD, three independent 
experiments, n = 60–80 cells per experiment. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 in B–D; Student’s t test. (E) Distribution of the PI4P GFP-
P4C probe in control, FAPP1-KD, ORP10-KD, and VAP-KD fixed HeLa cells. Bar, 10 µm. (F) The ratio between GFP-P4C fluorescence intensity in the Golgi and 
PM area. Means ± SD, three independent experiments, n = 30–43 cells/condition. (G and H) Evaluation of Golgi PI4P levels by mass assay. (G) Golgi fractions 
were isolated from control (CTRL), FAPP1-KD, and ORP10-KD HeLa cells (see Materials and methods). Western blot showing the distribution of a TGN protein 
(TGN46) and a PM protein (Na+/K+ ATPase) after sucrose gradient separation. Dashed rectangle, fractions enriched for Golgi markers. (H) Golgi fractions were 
incubated with 32P-ATP and, where indicated, with recombinant PIP5K1C. 32P-PI4,5P2 produced by PIP5K1C incubated with 3 µM porcine brain PI4P (PI4P, right 
lane) was taken as a reference for PI4,5P2. The amount of 32P-PI4,5P2 produced by PIP5K1C using PI4P present in Golgi fractions as a substrate was assessed 
by TLC and expressed as a percentage of control (graph). Means ± SD of three independent experiments.
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with different physical constraints and possibly distinct but inte-
grated functions (Fig. 5). Given that the width of ERTGoCS ranges 
from 5 to 20 nm (Venditti et al., 2019), the in-trans activity of Sac1 
may occur only at the tighter contact sites and only when FAPP1 is 
present. These sites, considering the low affinity of FAPP1 for PI4P 
(Kd: 18.6 µM; Levine and Munro, 2002), should also have initially 
elevated PI4P concentrations. In this way, FAPP1 acts at the same 
time as a PI4P detector and as an activator of Sac1, thus emerging 
as a pivotal regulator of the PI4P levels in the TGN and hence of 
PI4P-dependent physiological or pathological Golgi-based pro-
cesses (Balla, 2013; De Matteis et al., 2013). In the in-cis mode, Sac1 
acts on the PI4P pool that is transferred from the TGN to the ER by 
OSBP1. In this mode, Sac1 can operate also at contact sites that have 
a greater distance between the opposing membranes since OSBP1 
can in principle shuttle between the TGN and the ER (Fig. 5 A).
We propose that the paradigm of coexisting modes of Sac1 ac-
tivity at membrane contact sites might be extended to the plasma 
membrane (PM)–ER and endosome–ER contact sites where Sac1 
also patrols local pools of PI4P (Chung et al., 2015; Dickson et al., 
2016; Dong et al., 2016; Sohn et al., 2018; Zewe et al., 2018). While 
the requirements for the in-cis activity of Sac1 at the PM–ER and 
endosome–ER contact sites have been identified (Chung et al., 
2015; Dong et al., 2016; Sohn et al., 2018; Zewe et al., 2018), the 
possibility that FAPP1-like factors could act locally as activators 
of the in-trans activity of Sac1 on PM or endosomal PI4P has not 
been explored, with the exception of Osh3, which, in yeast, has 
been shown to be required for Sac1 activity on PM PI4P inde-
pendently of its lipid transfer activity (Stefan et al., 2011). We 
anticipate that our findings on FAPP1 activity at the ERTGoCS will 
foster the search for activators of the in-trans activity of Sac1 at 
other contact sites in mammalian cells.
Finally, we shed light on the physiological relevance of the role 
we have uncovered for FAPP1 and ERTGoCS as controllers of Golgi 
PI4P. By allowing the consumption of PI4P at the ERTGoCS, FAPP1 
exerts a negative control on PI4P levels and, as we have shown, on 
ApoB100 secretion. This finding reveals an unpredicted function 
for ERTGoCS. To date, membrane contacts have been regarded 
as structures that have a permissive/positive role in membrane 
remodeling events (Phillips and Voeltz, 2016; Caldieri et al., 2017). 
Here, we have provided an example of membrane contacts act-
ing as negative controllers of selected carrier budding at the TGN 
via their control of PI4P levels. Since only a fraction of the Golgi 
stacks is engaged in ERTGoCS (Venditti et al., 2019), one could en-
visage two possible scenarios: either the TGN of all the stacks has 
equivalent PI4P, in which case each Golgi stack engages in tran-
sient contacts with the ER, or the TGN of different stacks have 
heterogenous PI4P content, in which case only a subset of Golgi 
stacks engages in stable contacts with the ER while the remainder 
do not. Further, considering that ERTGoCS, by controlling PI4P 
levels, can negatively regulate the TGN export of ApoB100, one 
can envision that every stack can export ApoB100 at a low rate 
or that stacks with high rates of ApoB100 export coexist with 
stacks that do not export ApoB100 (Fig. 5 B). Resolving these is-
sues will require a high-resolution map of PI4P distribution and 
of ApoB100 carrier budding at the TGN.
Materials and methods
Reagents and antibodies
Primary antibodies used in this study were mouse monoclonal 
anti-HA and rabbit polyclonal anti-HA (Covance), mouse mono-
clonal anti-PI4P (Echelon), mouse monoclonal anti-His (Qiagen), 
rabbit polyclonal anti-Sac1 (Proteintech), rabbit polyclonal an-
ti-ORP9 (Sigma-Aldrich), rabbit polyclonal anti-ORP10 (Pierce), 
rabbit polyclonal anti–β-actin (Sigma-Aldrich), sheep polyclonal 
anti-TGN46 (Serotec), mouse monoclonal anti-Na+/K+ ATPase 
(Cell Signaling), and mouse monoclonal anti-Giantin (Abcam). 
Rabbit polyclonal antibodies against FAPP1, FAPP2, VAP-A, VAP-
B, GST (Venditti et al., 2012), Golgin-97, and ORP11 and rabbit 
polyclonal antibodies raised against full-length (FL) CERT and 
OSBP1 were obtained in our laboratories as described in Venditti 
et al. (2019). 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2- 
dioleoyl-sn-glycero-3-phospho-l-serine (DOPS), 1,2-dioleoyl-
sn-glycerol-3-[(N-(5-amino-1-carboxypentyl) iminodiacetic 
acid)succinyl] (DOGS-NTA-Ni; nickel salt), TopFluor-PI4P, and 
porcine brain PI4P were purchased from Avanti Polar Lipids. 
diC8-PI4P was purchased from Echelon Biosciences. DilC18 was 
purchased from Thermo Fisher Scientific. Recombinant PIP5K1C 
was purchased from ProQinase.
The following reagents were gifts: pSPO RT6-hSac1 and GFP-
P4M, from T. Balla (National Institutes of Health, Bethesda, 
Figure 2. FAPP1 interacts with VAPs and Sac1 and promotes the in-trans 4-phosphatase activity of Sac1 in vitro. (A) HeLa cells transfected with 
FAPP1-BioID2 or Sac1-BioID2 constructs were treated with 50 µM biotin. Biotinylated proteins were used in a PD assay with streptavidin-conjugated beads, 
resolved by SDS-PAGE, and immunoblotted with the indicated antibodies. (B) In vitro PD of GST-FAPP1 proteins (FL, residues 1–100, or residues 97–300) with 
His-tagged forms of Sac1 and VAPA showing direct binding to Sac1 (residues 1–522 and 1–188) and to VAPA. (C) Top: In vitro PD of His-Sac1 (residues 1–188) 
with GST-tagged VAPA and VAPB proteins. Bottom: GST-FAPP1 PD assay shows simultaneous binding with Sac1 (1–522) and VAPA. The asterisk indicates cross- 
reaction of the anti-His-antibody with FL-FAPP1. (D) SIM–super resolution images of endogenous FAPP1 localizing at ERTGoCS. Right panels: Magnification 
of boxed area; arrowheads indicate interposition of FAPP1 (green) between the TGN (TGN46 in blue) and the ER (Cb5 in red), as highlighted in the orthogonal 
projection (bottom). Bars, 1 µm. (E) Immuno-EM image showing FAPP1 localizing at the ERTGoCS. FAPP1 was enriched at the TGN as compared with earlier 
Golgi compartments, as previously described (Godi et al., 2004). (F) In vitro 4-phosphatase activity of liposome-bound His6-Sac1 (1–522) in the presence of GST-
FAPP1 (+FAPP1) or GST alone (without FAPP1) in the cis (solid line) or trans (dotted line) conformation (schematized above panel). The reaction was performed 
in 100 µl in the presence of 100 nM Sac1; 12.5 µl was taken at the indicated time points to measure phosphate release (see Materials and methods). Means ± 
SD, three technical replicates of a representative experiment, n = 3. (G) Effects of GST-FAPP1 or GST alone (w/o FAPP1) on liposome-bound His6-Sac1 (1–522) 
activity toward soluble diC8-PI4P. Means ± SD, three technical replicates of a representative experiment, n = 3. (H) Dose response of phosphate release in the 
trans conformation in the presence of increasing concentrations of GST-FAPP1. Means ± SD, three technical replicates of a representative experiment, n = 3 
(see Materials and methods for details). (I) OSBP1 but not FAPP1 can extract PI4P from membranes. 3 µM GST-OSBP1-FL (red line), GST-FAPP1-FL (green line) 
or GST (blue line) was added to liposomes containing TopFluor-PI4P and DilC18 (see Materials and methods).
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Figure 3. The stabilization of ERTGoCS decreases PI4P at the TGN in a FAPP1-dependent manner. (A) Schematic representation of the opto-ERTGoCS 
construct. (B) The optogenetic approach used to visualize ERTGoCS. In the absence of light (left), the ER-fused SsrA domain is enclosed in the C-terminal helix of 
the LOV domain (iLID construct). Blue light activation (488 nm, right) induces a conformational change that releases the SsrA domain, allowing its dimerization 
with the TGN-fused SspB domain and, in turn, ERTGoCS stabilization. (C) Representative images of HeLa cells transfected with the opto-ERTGoCS construct 
and with the PI4P probe P4M (PI4P). Cells were kept in the dark (left panels) and pulsed with blue light (488 nm; middle panels), and then the blue light was 
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MD); GFP-P4C from Y. Mao (Cornell University, Ithaca, NY); 
pcDNA3.1-VAPA and pGEX-VAPA from N. Ridgway (Atlan-
tic Research Centre, Dalhousie University, Halifax, Nova 
Scotia, Canada). Other plasmids used were pGEX-4T2 from GE 
Healthcare; pTrcHis2 and Champion pET-SUMO from Thermo 
Fisher Scientific; and iRFP-P4M-SidM (51470), Myc-BioID2-
MCS (74223), Venus-iLID-CAAX (60411), and tgRFPt-SspB WT 
(60415) from AddGene.
Media, serum, and reagents for tissue culture were pur-
chased from Thermo Fisher Scientific. Unless otherwise stated, 
all chemicals were purchased from Sigma-Aldrich.
Plasmid construction
All reagents for molecular biology were purchased from 
New England Biolabs. All mutagenesis was performed by 
site-directed mutagenesis (Agilent Technologies). The 
ERTGoCS reporter construct TGN46-FRB-HA-GFP-T2A- 
mCherry-FKBP-Cb5-pIRES-neo2 was generated as described 
in Venditti et al. (2019).
The optogenetics control system to visualize ER–Golgi ERT-
GoCS is based on light-induced dimerization of the bacterial pro-
teolysis tag peptide SsrA and its natural partner SspB with the ER 
reporter Cb5 and the TGN reporter TGN46, respectively. Without 
blue light stimulation (488 nm), the SsrA peptide is embedded 
in the C-terminal helix of the LOV domain. Upon photo-activa-
tion by illumination at 488 nm, the LOV helix unwinds, allow-
ing the heterodimerization of SsrA and SspB (Lungu et al., 2012; 
Guntas et al., 2015).
To generate the optogenetics ERTGoCS (opto-ERTGoCS) re-
porter construct, the PIPE cloning strategy for multiple PCR 
assembly was used to clone GFP, SspB, T2A-mCherry, and iLID 
(LOV and SsrA peptide) genes (Table S1) using the TGN46-FRB-
HA-GFP-T2A-mCherry-FKBP-Cb5-pIRES-neo2 as a template 
vector (replacing FRB-HA-GFP-T2A-mCherry-FKBP) to generate 
TGN46-GFP-SspB-T2A-mCherry-iLID-Cb5-pIRES-neo2.
All the cloning strategies adopted for generating the 
other plasmids used in this study are summarized in Table 
S1. The FAPP1, Sac1, VAP-A, and VAP-B plasmids refer to 
human sequences.
Cell culture, transfection, and RNA interference
HeLa cells and mouse embryonic fibroblasts (MEFs) were grown 
in high glucose (4,500 mg/l) DMEM supplemented with 10% FCS. 
HepG2 were grown in MEM supplemented with 1 mM sodium py-
ruvate, nonessential amino acids, and 10% FCS. HeLa WT and HeLa 
VAP-KO cell lines were a gift from P. De Camilli (Yale University 
School of Medicine, New Haven, CT). VAP-KO cells were gener-
ated by a TAL EN-based gene-editing approach with TAL EN pairs 
specific to exon 2 of VAPA and VAPB and were cultured as previ-
ously described (Dong et al., 2016). HeLa cells stably expressing 
the ERTGoCS pIRES-neo2 reporter and GFP-FAPP1 vectors were 
isolated as a clone obtained by single-cell–sorting procedures.
For transfection of DNA plasmids, HeLa cells were transfected 
using either TransIT-LT1 (Mirus Bio LLC, for BioID2 experiment) 
or JetPEI (Polyplus, for immunofluorescence analysis) as trans-
fection reagents, and the expression was maintained for 16 h be-
fore processing.
The following siRNA sequences were used in this study. Cells 
treated with identical concentrations of non-targeting siRNAs (D-
001810-01-20 and D-001810-02-20; Dharmacon) are referred to 
as controls. VAP-A: #1 5′-CAC AGA CCU CAA AUU CAA-3′, #2 5′-GGC 
AAA ACC UGA UGA AUUA-3′, #3 5′-CCU GAG AGA UGA AGG UUUA-
3′, #4 5′-CAA GGA AAC UAA UGG AAGA-3′; VAP-B: #1 5′-GUA AGA 
GGC UGC AAG GUGA-3′, #2 5′-CCA CGU AGG UAC UGU GUGA-3′, #3 
5′-UGU UAC AGC CUU UCG AUUA-3′, #4 5′-GUA AUU AUU GGG AAG 
AUUG-3′; FAPP1: #1 5′-CGA AGA ACC UAC UCA GAUA-3′, #2 5′-GCA 
UAA AGA UGG CAG UUUG-3′, #3 5′-UCA CAA CGC UUG AGG AAUG-
3′, #4 5′-GAA CCA GUA UCU ACA CUUC-3′; FAPP2: #1 5′-GAG AUA 
GAC UGC AGC AUAU-3′, #2 5′-GAA UUG AUG UGG GAA CUUU-3′, 
#3 5′-GAA AUC AAC CUG UAA UACU-3′, #4 5′-CCU AAG AAA UCC 
AAC AGAA-3′; OSBP1: #1 5′-CAC AAC UGU ACA CAA CAUU-3′, #2 
5′-GAU AGA UCA GUC UGG CGAA-3′; ORP9: #1 5′-GAG GAG CAC AAG 
AGC GUUA-3′, #2 5′-ACC AAG AAG UUG CCU AUAA-3′, #3 5′-GCU 
CAU AUC UGG ACC AAAU-3′, #4 5′-CCA AAG CGC UUA AUA GAUU-
3′; ORP10: #1 5′-CAA CCC AAC CAA CAC CAUU-3′, #2 5′-GGA UCA 
GCG UAG UAU AAUU-3′, #3 5′-AAU ACC ACA UGG AAA UGAA-3′; 
ORP11: #1 5′-GAG ACU UAA UUA GAC GAAU-3′, #2 5′-GAA UCU GGA 
CUA UUA GCGA-3′, #3 5′-GCG UGA CAA UGG UUG GAGA-3′; CERT: 
#1 5′-GAA GAU GAC UUU CCU ACAA-3′, #2 5′-GAA GUU GGC UGA 
removed (right panels). After blue light stimulation, Cb5 is recruited to the TGN46-GFP area (inset, middle panels) and P4M Golgi localization is reduced. After 
removal of blue light, Cb5 returns to the ER localization, and P4M intensity increases in the Golgi area. Bar, 10 µm. (D) Mean fluorescence intensity values ± 
SD of Cb5-mCherry (red) and P4M (gray) in the Golgi area (defined as TGN46-GFP localization; see Materials and methods) in control (left) and in FAPP1-KD 
cells (right). *, P < 0.05. (E) mCherry-LOV-SsrA-Cb5 localization and PI4P Golgi levels (detected by anti-PI4P antibody) in HeLa cells transfected with the 
opto-ERTGoCS construct in the dark (top panels), exposed to a blue-light pulse (middle panels) and after removal of light stimulus (bottom panels). Bar, 10 
µm. (F) Quantification of the ratio of PI4P and Golgin-97 fluorescence intensity in the Golgi area expressed as a percentage of maximum. Three independent 
experiments, n = 50. ***, P < 0.001; Student’s t test. (G and H) Schematic representation of constructs used to stabilize the ERTGoCS with rapamycin. (I) PI4P 
distribution in control, VAP-KD, FAPP1-KD, and VAP-KD+FAPP1-KD cells expressing TGN46-FRB-HA and mCherry-T2A-FKBP-Cb5 reporter proteins upon short 
(2 min rapamycin, middle panel) and prolonged (15 min rapamycin, right panel) stabilization of ERTGoCS. Inserts show Cb5 localization. Arrowheads indicate 
ERTGoCS formation. Bar, 10 µm. (J) Quantification of Golgi PI4P levels (solid lines) and number of cells forming ERTGoCS (dashed lines) in control, VAP-KD, 
FAPP1-KD, and VAP-KD+FAPP1-KD cells treated with 200 nM rapamycin for the indicated times. PI4P was detected using a monoclonal anti-PI4P antibody, and 
PI4P levels were calculated as the ratio between PI4P and Golgin-97 fluorescence intensity at the Golgi complex. PI4P values are expressed as a percentage of 
values in cells at time 0 (not exposed to rapamycin). ERTGoCS values are expressed as a percentage of cells showing colocalization of Cb5 with TGN46. Means 
± SD, three independent experiments; n = 60–100 cells. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; Student’s t test. (K) Golgi PI4P levels (solid 
lines) and number of cells forming ERTGoCS (dashed lines) in HeLa WT and VAP-KO cells treated with 200 nM rapamycin for the indicated times. PI4P levels 
were calculated as the ratio between PI4P and Golgin-97 fluorescence intensity at the Golgi complex. PI4P values are expressed as a percentage of values at 
time 0 (cells not exposed to rapamycin). ERTGoCS values are expressed as a percentage of cells showing colocalization of Cb5 with TGN46. Means ± SD, three 
independent experiments; n = 60–100 cells; Student’s t test.
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Figure 4. FAPP1 negatively controls ApoB100 export from the TGN in a PI4P-dependent manner. (A) Immunoblot of the medium and cell lysates from 
Mock, FAPP1-KD, or ORP10-KD cell cultures using the anti-ApoB100 antibody (see Materials and methods). (B) Quantification of the Western blot shown in A. 
Secretion of ApoB100 (ratio between the amount in the medium and in the cell lysates) expressed as a percentage of control (CTRL). Means ± SD, n = 3. *, P < 
0.05. (C) ApoB100 secretion evaluated by ELI SA from control (CTRL) or FAPP1-KD cells, expressed as the amount (ng) of ApoB100 in the medium normalized 
for the protein content. *, P < 0.05. n = 3. (D) ApoB100, albumin, and α1-anti-trypsin secretion evaluated by pulse-chase. Control or FAPP1-KD cells were 
incubated as described in Materials and methods. Secretion is expressed as a ratio between the amount of labeled cargo in the medium and the total labeled 
cargo (medium plus cell lysate). *, P < 0.05. n = 3. (E) Control, FAPP1-KD, and ORP10-KD HepG2 cells were stained with anti-PI4P (green) and anti–Golgin-97 
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AAU GGAA-3′, #3 5′-GCG AGA GUA UCC UAA AUUU-3′, #4 5′-UCA 
AAG GGA UAA AGU GGUA-3′; PI4KIIIβ: #1 5′-UCG GCU GAU AGU 
GGC AUG AUU-3′, #2 5′-UGG CGA CAU GUU CAA CUA CUA-3′, #3 
5′-CGA CAU GUU CAA CUA CUA UAA-3′.
HeLa and HepG2 cells were treated for 72 h with Oligofect-
amine (Life Technologies) or Dharmafect (Dharmacon), respec-
tively, for direct transfection. The knockdown efficiencies of 
siRNAs used in this study on target protein levels are expressed 
below as a percentage of residual protein in the knockdown com-
pared with the control (means of three experiments ± SD).
VAPA: 5.1 ± 2.4; VAPB: 4.2 ± 5.1; FAPP1: 9.2 ± 4.2 (HeLa cells), 
and 12.5 ± 5.2 (HepG2 cells); FAPP2: 20 ± 7.5; OSBP1: 15.8 ± 5.3 (in 
OSBP1 KD), 12.9 ± 3.5 (in ORP9 + OSBP1 KD), 18.7 ± 5.9 (in ORP10 + 
OSPB1 KD), and 16.9 ± 9.1 (in ORP11 + OSBP1 KD); ORP11: 4.5 ± 4.1 
(in ORP11 KD), 8.8 ± 6.1 (in ORP9 + ORP11 KD), 11 ± 5.9 (in ORP10 
+ ORP11 KD), and 10 ± 3.2 (in ORP11 + OSBP1 KD).
ORP10: 12.3 ± 7.5 (in ORP10 KD), 9.9 ± 9.9 (in ORP9 + ORP10 
KD), 13.2 ± 5.3 (in ORP10 + ORP11 KD), 10.3 ± 8.1 (in ORP11 + OSBP1 
KD), and 15.9 ± 7.3 (HepG2 cells); ORP9: 9.2 ± 4.1 (in ORP9 KD), 7.3 
± 5.7 (in ORP9 + ORP10 KD), 11.2 ± 4.9 (in ORP9 + ORP11 KD), and 
5.8 ± 8.7 (in ORP9 + OSBP1 KD).
Immunofluorescence analysis
HeLa or HepG2 cells were grown on coverslips and fixed with 
4% PFA for 10 min, washed three times with PBS, blocked, per-
meabilized for 30 min with blocking solution (0.05% sapo-
nin, 0.5% BSA, and 50 mM NH4Cl in PBS), and incubated with 
primary antibodies diluted in blocking solution for 1  h at RT. 
Coverslips were washed with PBS and incubated with fluorochrome- 
conjugated secondary antibodies (Alexa Fluor 488, Alexa Fluor 
568, and Alexa Fluor 633) for 1 h at RT. Fixed cells were mounted 
in Mowiol and imaged with Plan-Apochromat 63×/1.4 oil ob-
jective on a Zeiss LSM800 confocal system equipped with an 
Electronically Switchable Illumination and Detection (ESID) 
module and controlled by Zen Blue software. For live imaging of 
the P4M probe (Fig. S1 A), cells were plated in glass-bottomed 
dishes (MatTek), transfected with the P4M probe for 16 h, and 
imaged with an LSM800 microscope as described above. During 
imaging, cells were maintained in complete culture medium in a 
humidified atmosphere at 37°C. Fluorescence images presented 
are representative of cells imaged in at least three independent 
experiments and were processed with FIJI (ImageJ; National In-
stitutes of Health) software. Analysis of PI4P imaging and ER–
Golgi contact site quantification is described below and in the 
corresponding figure legends. Differences between groups were 
determined using the unpaired Student’s t test calculated with 
the GraphPad Prism software. All data are reported as means ± 
SD as indicated in the figure legends. For structured illumina-
tion microscopy (SIM; Fig. 2 D), cells were imaged with a Plan- 
Apochromat 63×/1.4 oil objective on a Zeiss LSM880 confocal 
system. Image stacks of 0.88 µm thickness were acquired with 
0.126 µm z-steps and 15 images (three angles and five phases per 
angle) per z-section. The field of view was ∼75 × 75 µm at 0.065 
µm/pixel, and a SIM grating of 34 µm was used. Image stacks 
were processed and reconstructed with Zen software, using the 
SIM tool in the processing palette.
Rapamycin-induced stabilization of ERTGoCS in cells 
expressing TGN46-FRB-HA and mCherry-FKBP-Cb5
Rapamycin-induced stabilization of ERTGoCS was performed 
as described in Venditti et al. (2019). Briefly, to follow the rapa-
mycin-induced stabilization of ERTGoCS, HeLa cells expressing 
TGN46-FRB-HA-GFP-mCherry-FKBP-Cb5 and treated with the 
appropriate siRNAs were pretreated with 50 µg/ml cyclohexi-
mide for 30 min, and then treated with 200 nM rapamycin at 
37°C at various time points, followed by PFA fixation. Both the 
cycloheximide and the rapamycin treatments were performed in 
complete growth medium at 37°C. Cells were then stained with 
the anti-HA antibody (to verify TGN46 expression) and with a 
Golgi marker (Golgin-97 to check the overall status of the cells). 
15–20 individual fields were imaged (for a total of 150–200 cells) 
and analyzed to assess mCherry-Cb5 localization. P values were 
calculated on the basis of mean values from at least three inde-
pendent experiments.
Immuno-EM
Cells were fixed with mixture of 4% PFA and 0.05% glutaralde-
hyde in 0.2 M Hepes for 10 min and then with 4% PFA alone for 30 
min, followed by incubation with blocking/permeabilizing solu-
tion for 30 min. Cells were incubated with the primary anti-GFP 
rabbit antibody overnight and then with 1.4 nm gold-conjugated 
Fab′ fragment of anti-rabbit IgGs for 2 h. A GoldEnhance EM kit 
(Nanoprobes) was used to enhance ultrasmall gold particles. The 
cells were then scraped, pelleted, postfixed in OsO4 and uranyl 
acetate, and embedded in Epon.
Generation of FAPP1-KO MEFs
The protocol used to generate FAPP1 KO mice was that described 
for FAPP2 KO mice in D’Angelo et al. (2013). Briefly, the FAPP1 
gene was isolated from a mouse genomic BAC library derived 
from the 129Sv/J mouse strain (RPCI-22; Children’s Hospital 
Oakland Research Institute, Oakland, CA). An FRT-flanked SA-
IRES-β-geo-polyA cassette with an upstream loxP site was in-
serted into intron 5 and a loxP site was introduced into intron 
(red) antibodies. Bar, 10 µm. (F) Quantification of PI4P levels shown in E. n = 3; ***, P < 0.001. (G) Golgi-to-PM transport of ApoB100 in control and FAPP1-KD 
HepG2 cells. Representative images of the distribution of ApoB100 (anti-ApoB100 staining) under steady-state conditions, after a temperature block at 20°C, 
and after 15 and 60 min of the release from the 20°C temperature block. Insets, Golgin-97 staining. Bar, 10 µm. (H) Golgi-to-PM transport of ApoB100 in 
control, FAPP1-KD, ORP10-KD, FAPP1+PI4KIIIβ-KD, and ORP10+PI4KIIIβ-KD HepG2 cells. Quantification of Golgi emptying was performed by measuring the 
ratio between the ApoB100 signal and the Golgin-97 signal at the indicated times after release of the temperature block. Data are means ± SD expressed as 
a percentage of the ApoB100 signal in the Golgi compared with the signal at time 0 (i.e., at the end of the temperature block). n > 100; three independent 
experiments. **, P < 0.01; ***, P < 0.001; Student’s t test. (I) Control and FAPP1-KD HepG2 cells were treated as described in G, and analyzed after 15 min of the 
release of the 20°C block. Cells were stained for ApoB100 (gray), Golgin-97 (G97 inset), and COPI (blue). Bar, 10 µm. The arrowheads indicate ApoB100-positive 
peripheral structures that are probably post-Golgi carriers since they lack a COPI coat.
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7 in the FAPP1 targeting vector. This construct was used for the 
generation of the heterozygous FAPP1 geo/+ mice. Homozygous 
FAPP1 geo/geo mice (FAPP1 KO mice) were obtained by mating. 
The absence of FAPP1 was verified by Western blot and by PCR 
analysis. The PCR primers used were 5′-AAA ACA CCC AGT GGT 
CAG GCT AGCA-3′ (Primer 1), 5′-ATA ACT GAG CAC CAG GAG GAG 
AAGG-3′ (Primer 2), and 5′-CCG TAC AGT TCC ACA AAG GCA TCCT-
3′ (Primer 3), where primer pair 1 and 2 detected the WT allele 
and primers 1 and 3 detected the geo allele of FAPP1.
All animal procedures were performed in accordance with the 
guidelines of the Animal Care and Experimentation Committee 
of Gunma University, and all animals were bred in the Institute 
of Animal Experience Research of Gunma University.
MEFs were isolated from E13.5 embryos. Three embryos 
were pooled to generate each single MEF clone. Briefly, after 
isolation and removal of  internal organs, the embryos were 
trypsinized (0.125% trypsin-EDTA) at 37°C for 15 min and 
put in culture in DMEM with 20% FCS plus amphotericin 
and penicillin/streptomycin for the first week and kept for 
several passages.
PI4P detection
PI4P was detected by four independent approaches: three based 
on the imaging of PI4P in living or fixed cells and one on a bio-
chemical PI4P mass assay on isolated Golgi fractions using re-
combinant PIP5K1C.
Figure 5. Models of the distribution of modes of action of 
Sac1 and of the distribution of ERTGoCS and PI4P among 
Golgi stacks. (A) Two possible modes of action of Sac1 at 
the ERTGoCS. The width of ERTGoCS ranges from 5 to 20 nm 
(Venditti et al., 2019). We envisage that the in-trans activity of 
Sac1 may occur only at the tighter contact sites and only when 
FAPP1 is present. In the cis mode, Sac1 acts on PI4P that is 
transferred from the TGN to the ER by OSBP1 in exchange for 
cholesterol. In this mode, Sac1 can also operate at contact sites 
that have a greater distance between the opposing membranes 
since OSBP1 can in principle shuttle between the TGN and the 
ER. (B) Two possible scenarios of ERTGoCS and PI4P distribution 
among Golgi stacks. I: The TGN of every Golgi stack can engage 
in ERTGoCS at any given time. PI4P levels are kept equal and 
at a medium level in the TGN of all the stacks. ApoB100 export 
also occurs from the TGN of every stack but at a low rate. II: Only 
TGN from a subset of Golgi stacks can engage in ERTGoCS. PI4P 
levels are heterogeneous in the TGN of different stacks, some 
with high levels of PI4P (devoid of ERTGoCS) and others with low 
PI4P levels. ApoB100 export occurs exclusively and at a high rate 
from a TGN with high PI4P levels.
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PI4P was detected using three independent imaging approaches: 
staining of PI4P with a monoclonal anti-PI4P antibody (Echelon) 
following the protocol described by Hammond et al. (2009), de-
tection of PI4P using two different genetically encoded probes 
(P4M and P4C, corresponding to the PI4P-binding domains of 
the two Legionella pneumophila effectors SidM and SidC, respec-
tively; Hammond et al., 2014; Luo et al., 2015), and staining of 
PI4P in streptolysin O (SLO)–permeabilized cells with a recom-
binant PI4P probe produced in Escherichia coli (GST-FAPP PH 
domain) as previously described (Godi et al., 2004).
Quantification of Golgi PI4P stained with the anti-PI4P antibody
Hela cells were double stained for PI4P and for the TGN with 
anti-PI4P and anti-Golgin-97 antibodies, respectively, following 
the protocol of Hammond et al. (2009). Briefly, cells were fixed 
with 2% PFA for 15 min at RT, washed three times in PBS sup-
plemented with 50 mM NH4Cl, and permeabilized for 5 min by 
the addition of 20 µM digitonin in Buffer A (20 mM Pipes, pH 
6.8, 137 mM NaCl, and 2.7 mM KCl) for 5 min. After three rinses 
in Buffer A, cells were blocked for 45 min with blocking solu-
tion (Buffer A supplemented with 5% [vol/vol] FBS and 50 mM 
NH4Cl) and incubated with primary antibodies diluted in block-
ing solution for 1 h. Cells were then washed with Buffer A, in-
cubated with fluorescence-conjugated secondary antibodies for 
1 h, and finally postfixed for 5 min in 2% PFA. 10–15 fields (each 
containing 10–15 cells) were randomly sampled and imaged at 
the same microscope settings (i.e., laser power and detector am-
plification) and below pixel saturation. The mean intensity per 
cell was determined using the ImageJ software. For PI4P level 
assessment, a mask using the TGN marker Golgin-97 was gen-
erated for each cell, and the mean intensities of both PI4P and 
Golgin-97 were measured in those regions. After background 
subtraction, the PI4P values were normalized singularly using 
their own Golgin-97 values.
Quantification of Golgi PI4P detected with P4C
Both P4M and P4C, expressed for 16 h in HeLa cells, exhibited 
a clear Golgi localization in living cells, but only P4C preserved 
a strong association with the Golgi complex after fixation, con-
sistent with its higher affinity for PI4P as compared with P4M 
(Luo et al., 2015). Quantification of Golgi PI4P detected with P4C 
was performed both in live cells by fluorescence loss in photo-
beaching (FLIP) and in fixed cells. FLIP was performed in cells 
expressing GFP-P4C by bleaching iteratively (100 times) the 
GFP-associated fluorescence in the entire cell area except for the 
Golgi area and monitoring the Golgi-associated fluorescence over 
time. The relative fluorescence intensity, expressed as a percent-
age of prebleaching fluorescence, was plotted. Reflecting the in-
crease in Golgi PI4P, the depletion of VAPs and FAPP1 induced a 
slowdown of the FLIP-induced decay curves of P4C from the Golgi 
area. For quantification of P4C associated with the Golgi complex 
in fixed cells, HeLa cells expressing GFP-P4C were stained for a 
TGN marker (Golgin-97) used to generate a mask in the Golgi re-
gion. The mean intensity of GFP-P4C was measured in the Golgi 
region and normalized for the mean intensity of an equivalent 
area outside the Golgi region. Golgi PI4P was expressed as the 
ratio between GFP-P4C fluorescence intensity in the Golgi region 
and in the equivalent extra-Golgi area.
Quantification of the GST-FAPP PH domain on the Golgi com-
plex was performed as described (Godi et al., 2004): cells were 
incubated with 1 U/ml SLO in SLO buffer (20  mM Hepes, pH 
7.2, 110 mM Mg(OAc)2, and 1 mM DTT) for 10 min at 4°C. Cells 
were then washed twice and incubated in permeabilization buf-
fer (25 mM Hepes, pH 6.95, 125 mM KOAc, 2.5 mM Mg(OAc)2, 
10 mM glucose, 1 mM DTT, 1 mM ATP, 5 mM creatine phosphate, 
7.3 U/ml creatine phosphokinase, and 1 mg/ml rat liver cytosol) 
for 5 min at 37°C and then in permeabilization buffer containing 
1 µM of GST or GST–FAPP-PH for an additional 5 min. Cells were 
then fixed with 4% PFA and processed for immunofluorescence 
microscopy, as described above. Quantification was performed as 
described above for the PI4P antibody, with the exception that the 
Golgi marker used was Giantin instead of Golgin-97.
PI4P mass assay with recombinant PIP5K1C
Golgi fractions, identified as fractions enriched for Golgi markers 
and devoid of PM markers, were isolated as described (Balch et 
al., 1984). Golgi fractions (60 µg) were washed with 0.2 M KCl in 
20 mM Hepes, pH 7.4, and 10 mM MgCl2 and centrifuged at 14,000 
rpm for 20 min. Pellets were resuspended in 20 mM Hepes and 
incubated for 30 min at 32°C in reaction buffer (20 mM Hepes, 
pH 7.4, 10 mM MgCl2, 40 µM ATP, and 200 µM sodium orthovana-
date) with 2 µCi [γ-32P]-ATP, in the presence or absence of 30 ng 
of recombinant PIP5K1C in a final reaction volume of 100 µl. The 
reaction was stopped by adding 20 µl 8 M HCl, and lipids were 
extracted with chloroform: methanol (1:1). The organic phase was 
dried and spotted on silica-gel TLC plates (Millipore), resolved 
with a mixture of chloroform: methanol: ammonium hydroxide: 
water (60:47:2:11 vol/vol/vol/vol), and analyzed by TLC. A sam-
ple where PIP5K1C was incubated with 3 μM porcine brain PI4P 
in reaction buffer with 2 µCi [γ-32P]-ATP was taken as a refer-
ence for PI4,5P2. The radioactive products were detected with a 
Typhoon TLA 9500.
BioID2 experiments and immunoprecipitation
HeLa cells were transfected with the Sac1-BioID2 or FAPP1- 
BioID2 constructs. 16 h post-transfection, cells were incubated 
with 50 µM biotin for an additional 24 h before lysis and pro-
cessed as described by Roux et al. (2013).
Cell extracts from untransfected HeLa cells or cells express-
ing GFP-FAPP1 or GFP-Sac1 were immune-precipitated usingan-
ti-GFP antibody, and the immune-precipitates were analyzed by 
Western blot or by liquid chromatography-tandem mass spec-
trometry (Central Proteomics Facility, Sir William Dunn Pathol-
ogy School, Oxford University, Oxford, UK). Control immune 
precipitates were obtained with anti-GFP antibody in cells ex-
pressing soluble GFP.
Recombinant proteins and pull-down (PD) experiments
All recombinant proteins were expressed in BL21 DE3 or Rosetta 
DE3 E. coli (Merck). GST-tagged proteins (FAPP1-FL, FAPP1 resi-
dues 1–100, FAPP1 residues 97–300, VAPA, VAPB, and GST alone) 
expressed from the pGEX plasmid were purified using Glutathi-
one Sepharose 4B (GE Healthcare). His-tagged proteins expressed 
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from pTrcHis2 (Sac1 residues 1–522 and Sac1 residues 1–188), and 
the His-SUMO-tagged proteins (FAPP1, VAPA, and VAPB), were 
purified using Ni-NTA agarose (Qiagen), according to the man-
ufacturer’s instructions. The PD experiments were performed as 
previously described (Venditti et al., 2012). Briefly, 0.2 µM His-
tagged proteins (Sac1 FL, 1–522 and 1–188 forms, and VAPA; Fig. 2) 
were incubated with GST-fusion proteins (FAPP1 FL, 1–100, or 
97–300 forms, VAPA and VAPB) and GST alone (0.2 µM). After 
overnight incubation at 4°C in 300 µl binding buffer (50 mM 
Tris, pH 7.4, 100 mM NaCl, 1 mg/ml BSA, 0.1% Triton X-100, and 
0.1% NP-40), glutathione-beads were added, incubated for 2 h at 
4°C, washed five times (50 mM Tris, pH 7.4, and 100 mM NaCl), 
eluted, and analyzed by SDS-PAGE.
Liposome preparation, Sac1 phosphatase, and PI4P 
extraction assays
PI4P-containing liposomes were prepared starting from lipid 
stock solutions in chloroform using the following molar ratios 
of lipids: DOPC, 45%; DOPE, 20%; DOPS, 5%; and porcine brain 
PI4P, 30%. Lipid mixtures in chloroform were dried under a 
nitrogen stream in a glass tube and hydrated in 50 mM Hepes, 
pH 7.4, 120 mM KAc, and 1 mM MgCl2 to produce a 2-mM lipid 
suspension. Lipid suspensions were transferred to LoBind tubes 
(Eppendorf), subjected to six freeze–thaw cycles (frozen in liquid 
nitrogen and thawed at 37°C), and extruded using a polycarbon-
ate membrane with a pore diameter of 100 nm.
To measure the in-cis activity of Sac1, 2 mol% DOGS-Ni-NTA 
was used in the preparation of the PI4P-containing liposomes at 
the expense of DOPC. The DOGS-Ni-NTA–containing liposomes 
were preincubated for 30 min at RT with 6xHis-hSac11–522 (0.5 µM) 
to allow binding of the protein to the lipids. 20 µl of the liposomes 
was transferred to a well of a 384-well plate and brought to 100 µl 
with the addition of reaction buffer (50 mM Hepes, pH 7.4, 120 mM 
KAc, and 1 mM MgCl2). Since hSac1 needs to be in a reduced con-
formation to be enzymatically active in vitro, 1  mM DTT was 
added to start the reactions that were performed at 32°C. Aliquots 
(12.5 µl) of the mixture were withdrawn at different time points 
and added to 10 µl of 200 mM N-Ethylmaleimide to stop the reac-
tion. Sac1 phosphatase activity was measured based on the amount 
of phosphate released in solution by adding 50 µl of malachite 
green reagent and reading the absorbance at 620 nm after 20 min.
To measure the in-trans activity of Sac1, 6xHis-hSac11–522 
(0.5 µM) was preincubated for 30 min at RT with 2 mM DOPC 
liposomes containing 2 mol% DOGS-Ni-NTA. 20 µl of these lipo-
somes were mixed with 20 µl of PI4P-containing liposomes and 
60 µl of DTT-containing reaction buffer and assayed as above. 
In agreement with previous reports (Mesmin et al., 2013), the 
spontaneous in-trans activity of Sac1 is low (Fig. 2 F), and the lag 
phase observed under these conditions is likely due to the fact 
that Sac1 is allosterically stimulated by its product, PtdIns (Zhong 
et al., 2012). This explains why the reaction is slower, showing a 
lag, at the very beginning of the in-trans reaction, i.e., when the 
product concentration is particularly low. To measure the effects 
of FAPP1, either GST or GST-FAPP1 was added to the reaction 
mixture at the indicated final concentrations.
To measure Sac1 activity on soluble PI4P, 1 µM 6xHis-hSac11–522 
was incubated for 30 min at RT with 2  mM DOPC liposomes 
containing 2 mol% DOGS-Ni-NTA. 40 µl of these liposomes were 
mixed with 100 µM diC8-PI4P in reaction buffer.
PI4P extraction from membranes was measured using lipo-
somes having the following molar ratio of lipids: DOPC, 68%; 
DOPE, 19%; DOPS, 5%; 2% TopFLU OR-PI4P; and 6% DilC18, which 
quenches TopFLU OR-PI4P fluorescence when present on the 
same vesicle. TopFLU OR-PI4P release from vesicles results in an 
increase in the fluorescence emission (Ex485/Em520).
Liposome tethering assay
The liposome tethering assay was performed as described in 
Saheki et al. (2016). Briefly, 6xHis-hSac11–522 (1 µM) was preincu-
bated for 30 min at RT with 2 mM DOPC liposomes containing 2 
mol% DOGS-Ni-NTA. 10 µl of these liposomes were mixed with 
10 µl of PI4P-containing liposomes and 30 µl reaction buffer con-
taining either FAPP1 (at the indicated concentrations) or a His-
tagged version of the PH domain of FAPP1 (6xHis-GST-FAPP1 PH 
domain) that binds both DOGS-Ni-NTA liposomes containing 
Sac1 (via its His tag) and the PI4P-containing liposomes (via the 
PH domain of FAPP1), thus acting as a tether between the two 
liposome populations. Liposome aggregation was assessed by 
measuring the absorbance at 405 nm every 15 s over 15 min at 
32°C using a Neo2 Microplate Reader (Biotech). The absorbance 
before protein addition was set to 0.
Optogenetics
The optogenetics control system to visualize ERTGoCS is based 
on light-induced dimerization of the iLID (Lungu et al., 2012; 
Guntas et al., 2015) adapted version described in the plasmid 
construction section.
HeLa cells cotransfected with the opto-ERTGoCS and iR-
FP-P4M constructs were analyzed using time-lapse microscopy. 
The mCherry-LOV-SsrA-Cb5 conformational change was induced 
using one blue light–enhanced pulse (100% power 488 nm laser) 
followed by acquisition of the three channels. This procedure was 
repeated each frame during the illumination step only (∼10 min).
Before and after illumination, images were acquired using 
the mCherry channel in order to analyze mCherry-LOV- 
SsrA-Cb5 localization, and the GFP channel was only acquired 
during illumination to analyze TGN-GFP-SspB. The reversibil-
ity was performed by image acquisition for the same period of 
time, removing the 488-nm pulses. PI4P levels were measured 
throughout the entire acquisition using the iRFP670 channel. 
The time-lapse images from the three channels were combined 
in series using ImageJ and the region of interest defined by the 
GFP signal after illumination. The fluorescence intensity of each 
mCherry-Cb5 and iRFP-P4M frame was measured using the re-
gion of interest and plotted after background subtraction as a 
percentage of the starting point.
For selected experiments, HeLa cells were transfected with 
the opto-ERTGoCS, subjected to activation with blue light, fixed, 
and stained for a TGN marker (Golgin-97) and PI4P.
ApoB100 secretion
HepG2 cells were incubated for the indicated times in MEM con-
taining 5% delipidated serum. ApoB100 in cell lysates and in the 
medium was determined using both Western blot with a specific 
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antibody (Rockland Immunochemicals) and a sandwich ELI SA 
(Mabtech), as described in Nissilä et al. (2012).
For pulse-chase experiments, HepG2 cells were grown in 10% 
FBS/MEM. After mock or siRNA treatment, cells were washed 
with warm PBS and incubated in pulse medium (methionine/
cysteine-free DMEM) supplemented with 2  mM l-glutamine 
(Sigma-Aldrich) and 100 µCi ml-1 [35S]-methionine/cysteine 
(NEG77200; EasyTag Express Protein Labeling Mix; Perkin-
Elmer) for 30 min for ApoB100 and 5 min for albumin and α1- 
anti-trypsin, as previously described (Nissilä et al., 2012; Venditti 
et al., 2012). The media and cell lysates were immunoprecipitated 
using specific antibodies, analyzed by Western blot, and quanti-
fied with Typhoon TLA 9500. The ratio between the labeled cargo 
(ApoB100, albumin, and α1-anti-trypsin) in the supernatant and 
the total amount (supernatant plus cell lysate) was taken as mea-
sure of secretion at the indicated times.
ApoB100 trafficking out of the Golgi complex was imaged, 
adopting a synchronization protocol. HepG2 cells were seeded 
onto coverslips for 72 h and then incubated at 20°C for 8 h in 
MEM supplemented with 5% delipidated serum to favor the accu-
mulation of ApoB100 in the TGN. To allow TGN exit of ApoB100, 
the temperature was shifted to 37°C for the indicated times (in 
the same medium with addition of 50 µg ml−1 cycloheximide). At 
various times, cells were fixed (4% PFA, 10 min, RT) and stained 
for ApoB100 and for TGN (using the anti-ApoB100 and anti- 
Golgin 97 antibodies).
The amount of ApoB-100 in the Golgi was calculated by mea-
suring the ApoB100 signal in Golgin-97–positive structures. The 
value measured at time 0 at the end of the 20°C block was taken 
as 100%. At least 100 cells for each time point were acquired 
below saturation level and analyzed, using ImageJ software.
Online supplemental material
Fig. S1 shows how the depletion of VAPs, ORP10, or FAPP1 in-
creases Golgi PI4P. Fig. S2 shows that FAPP1 interacts with VAP 
and with Sac1 and stimulates the in-trans phosphatase activity of 
Sac1. Table S1 shows a list of primers and cloning strategies used 
in this study. Video 1 shows the reversible light-induced stabiliza-
tion of ERTGoCS and the decrease of TGN PI4P via optogenetics.
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